The prognosis of recurrent low-grade endometrial stromal sarcoma: a retrospective cohort study.
Qianwen DaiBaolin XuHuanwen WuYan YouMing WuLei LiPublished in: Orphanet journal of rare diseases (2021)
For patients with recurrent LGESS, fertility-sparing treatment or ovarian preservation should not be provided. Surgery is the treatment of choice, and hormone treatment and/or chemotherapy was effective for the survival benefits of surgical treatment.